María Carmona-Iragui Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau Universitat Autònoma de Barcelona Biography Publications Institution JoVE Articles María Carmona-Iragui has not added a biography. If you are María Carmona-Iragui and would like to personalize this page please email our Author Liaison for assistance. Publications DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients Biomedicines. Jun, 2022 | Pubmed ID: 35740400 Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome JAMA Network Open. 05, 2022 | Pubmed ID: 35604690 Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease Neurology. 06, 2022 | Pubmed ID: 35470138 Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications International Journal of Molecular Sciences. Apr, 2022 | Pubmed ID: 35457126 The Aβ1-42/Aβ1-40 Ratio in CSF is More Strongly Associated to Tau Markers and Clinical Progression Than Aβ1-42 Alone Alzheimer's Research & Therapy. 02, 2022 | Pubmed ID: 35105351 Risk of Intracranial Haemorrhage and Ischaemic Stroke After Convexity Subarachnoid Haemorrhage in Cerebral Amyloid Angiopathy: International Individual Patient Data Pooled Analysis Journal of Neurology. Mar, 2022 | Pubmed ID: 34272978 Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Chain for the Diagnostic and Prognostic Evaluation of Frontotemporal Dementia Translational Neurodegeneration. 12, 2021 | Pubmed ID: 34893073 Alzheimer's Disease Associated with Down Syndrome: a Genetic Form of Dementia The Lancet. Neurology. 11, 2021 | Pubmed ID: 34687637 Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome Journal of Clinical Medicine. Aug, 2021 | Pubmed ID: 34442043 Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society Molecular Syndromology. Jul, 2021 | Pubmed ID: 34421499 Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome Annals of Neurology. 09, 2021 | Pubmed ID: 34309066 Diagnostic and Prognostic Performance and Longitudinal Changes in Plasma Neurofilament Light Chain Concentrations in Adults with Down Syndrome: a Cohort Study The Lancet. Neurology. 08, 2021 | Pubmed ID: 34302785 Phosphorylated Tau181 in Plasma As a Potential Biomarker for Alzheimer's Disease in Adults with Down Syndrome Nature Communications. 07, 2021 | Pubmed ID: 34262030 Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome JAMA Neurology. 08, 2021 | Pubmed ID: 34228042 Use of Plasma Biomarkers for AT(N) Classification of Neurodegenerative Dementias Journal of Neurology, Neurosurgery, and Psychiatry. 11, 2021 | Pubmed ID: 34103344 Medical Vulnerability of Individuals with Down Syndrome to Severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C Survey EClinicalMedicine. Mar, 2021 | Pubmed ID: 33644721 Nerve Growth Factor (NGF) Pathway Biomarkers in Down Syndrome Prior to and After the Onset of Clinical Alzheimer's Disease: A Paired CSF and Plasma Study Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 04, 2021 | Pubmed ID: 33226181 Biphasic Cortical Macro- and Microstructural Changes in Autosomal Dominant Alzheimer's Disease Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 04, 2021 | Pubmed ID: 33196147 Evaluation of Biochemical and Hematological Parameters in Adults with Down Syndrome Scientific Reports. 08, 2020 | Pubmed ID: 32792619 Obesity Impacts Brain Metabolism and Structure Independently of Amyloid and Tau Pathology in Healthy Elderly Alzheimer's & Dementia (Amsterdam, Netherlands). 2020 | Pubmed ID: 32743041 Clinical and Biomarker Changes of Alzheimer's Disease in Adults with Down Syndrome: a Cross-sectional Study Lancet (London, England). 06, 2020 | Pubmed ID: 32593336 The Sant Pau Initiative on Neurodegeneration (SPIN) Cohort: A Data Set for Biomarker Discovery and Validation in Neurodegenerative Disorders Alzheimer's & Dementia (New York, N. Y.). 2019 | Pubmed ID: 31650016 Trisomy 21 Activates the Kynurenine Pathway Via Increased Dosage of Interferon Receptors Nature Communications. 10, 2019 | Pubmed ID: 31628327 Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine. 10, 2018 | Pubmed ID: 30353801 Challenges Associated with Biomarker-based Classification Systems for Alzheimer's Disease Alzheimer's & Dementia (Amsterdam, Netherlands). 2018 | Pubmed ID: 30175226 Monoaminergic Impairment in Down Syndrome with Alzheimer's Disease Compared to Early-onset Alzheimer's Disease Alzheimer's & Dementia (Amsterdam, Netherlands). 2018 | Pubmed ID: 29780859 Cortical Microstructural Changes Along the Alzheimer's Disease Continuum Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 03, 2018 | Pubmed ID: 29080407 Weight Loss in the Healthy Elderly Might Be a Non-cognitive Sign of Preclinical Alzheimer's Disease Oncotarget. Dec, 2017 | Pubmed ID: 29285207 Diagnostic and Prognostic Value Of the Combination of Two Measures Of Verbal Memory in Mild Cognitive Impairment Due to Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 28527215 Cerebral Amyloid Angiopathy in Down Syndrome and Sporadic and Autosomal-dominant Alzheimer's Disease Alzheimer's & Dementia : the Journal of the Alzheimer's Association. Nov, 2017 | Pubmed ID: 28463681 Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 27858714 Periodontal Disease's Contribution to Alzheimer's Disease Progression In Down Syndrome Alzheimer's & Dementia (Amsterdam, Netherlands). 2016 | Pubmed ID: 27239536 Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias Journal of Alzheimer's Disease : JAD. 2016 | Pubmed ID: 26682689 Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation Journal of Alzheimer's Disease : JAD. 2016 | Pubmed ID: 26639966 Amyloid Precursor Protein Metabolism and Inflammation Markers in Preclinical Alzheimer Disease Neurology. Aug, 2015 | Pubmed ID: 26180139 Relationship Between Cortical Thickness and Cerebrospinal Fluid YKL-40 in Predementia Stages of Alzheimer's Disease Neurobiology of Aging. Jun, 2015 | Pubmed ID: 25865441 Cerebral Amyloid Angiopathy-related Atraumatic Convexal Subarachnoid Hemorrhage: an ARIA Before the Tsunami Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. May, 2015 | Pubmed ID: 25735919 Relationship Between β-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2014 | Pubmed ID: 24820015 Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: a Multicenter Study in Spain Journal of Alzheimer's Disease : JAD. 2014 | Pubmed ID: 24254700 Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma Natalia Valle-Tamayo1,2, Rocío Pérez-González2,3, Gemma Chiva-Blanch4,5, Olivia Belbin1,2, Sara Serrano-Requena1,2, Sònia Sirisi1,2, Alba Cervantes González1,2, Oriol Giró4,5, Érika Sánchez-Aced1,2, Oriol Dols-Icardo1,2, Daniel Alcolea1,2, María Carmona-Iragui1,2, Amanda Jimenez4,5, Alberto Lleó1,2, Juan Fortea1,2, M. Florencia Iulita1,2 1Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, 2Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), 3Movement Disorders Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, 4Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute - IDIBAPS, 5Spanish Biomedical Research Network in Physiopathology of Obesity and Nutrition (CIBEROBN) JoVE 64107 Neuroscience
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma Natalia Valle-Tamayo1,2, Rocío Pérez-González2,3, Gemma Chiva-Blanch4,5, Olivia Belbin1,2, Sara Serrano-Requena1,2, Sònia Sirisi1,2, Alba Cervantes González1,2, Oriol Giró4,5, Érika Sánchez-Aced1,2, Oriol Dols-Icardo1,2, Daniel Alcolea1,2, María Carmona-Iragui1,2, Amanda Jimenez4,5, Alberto Lleó1,2, Juan Fortea1,2, M. Florencia Iulita1,2 1Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, 2Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), 3Movement Disorders Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, 4Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute - IDIBAPS, 5Spanish Biomedical Research Network in Physiopathology of Obesity and Nutrition (CIBEROBN) JoVE 64107 Neuroscience